MSA
RESEARCH
CURRENT TRIALS
BASIC SCIENCE RESEARCH
NEW PROMISING MSA DISEASE MODIFYING DRUG TRIAL
BHV-3241 is a first-in-class, brain-penetrant, irreversible myeloperoxidase (MPO) inhibitor that is being developed for the treatment of multiple system atrophy (MSA).
- Has the potential to be developed in a number of disease indications associated with oxidative stress, inflammation, and neurodegeneration.
- Potential to be a first-in-class and best-in-class agent.
- Licensed from AstraZeneca in September 2018, where it was known as AZD3241.
MSA is a rare disease, affecting approximately 15,000 to 50,000 Americans. Some symptoms can be treated with medications but currently, there is no cure. Enter BioHaven, they are testing a new clinical drug that may slow MSA, multiple system atrophy (MSA). Check out MSA research study site:www.MSAresearchstudy.com
NEW NOVEL DRUG RESEARCH – PBT434
Happy to announce that PBT434 was granted orphan designation in USA & EU for Multiple System Atrophy; the maker Alterity, an Australian company plans to hold a clinical trial in Australia: https://alteritytherapeutics.com/ā¦/european-commission-appā¦/
NEW PRE-CLINICAL MSA RELEVANT RESEARCH SUCCESS
CONGRATS TO DAVID MARMION ON HIS NEW MSA RESEARCH!
āThere is an important role of the immune system to the pathophysiology of other synuclein-related diseases such as Parkinsonās disease. ā
āThese results suggest that T cell priming and infiltration into the CNS are key mechanisms of disease pathogenesis in MSA, and therapeutics targeting T cells may be disease modifying.ā
https://link.springer.com/article/10.1007/s00401-020-02126-w
#defeatmsa #msaresearch #msashoe
Photo Below: David Marmion helps #kickmsa !
RESEARCHER BLOG

Dr. Amanda Woerman

Dr. Wouter Peelaerts
Member, Science and Medical Advisory Board
THEĀ EXPERTS
A SPECIAL THANKS TO OUR MSA RESEARCHERS & HEALTH PROFESSIONALS AROUND THE WORLD!
DISCLAIMER
Any of these online pages published by Defeat MSA Down Under are for informational and support purposes only. The information presented in them should not be used for suggesting any diagnosis or understood as recommending any medicines, tests or treatments. Every visitor should consult with his/her doctor or other health care provider for any medical condition.
Furthermore, Defeat MSA Down Under has used all reasonable care to protect your privacy, ensure confidentiality and maintain a safe and secure online presence. For questions about the website or information contained therein, contact: msadownunder@gmail.com
LOOKING FOR OTHER WAYS TO GET INVOLVED?
JOIN THE MOVEMENT TOĀ #DEFEATMSA
Follow us on Twitter
Follow us on Facebook
Follow us on Instagram
Follow us on YouTube
Follow us on LinkedIn
Follow us on Twitter
Follow us on Facebook
Follow us on Instagram
Follow us on LinkedIn
Follow us on YouTube